GeneDx Hldgs Q3 Adj EPS $(1.22) Beats $(1.31) Estimate, Sales $53.30M Beat $52.41M Estimate

GeneDx Holdings Corp Ordinary Shares - Class A +4.54% Pre

GeneDx Holdings Corp Ordinary Shares - Class A

WGS

8.52

8.52

+4.54%

0.00% Pre

GeneDx Hldgs (NASDAQ: WGS) reported quarterly losses of $(1.22) per share which beat the analyst consensus estimate of $(1.31) by 6.87 percent. This is a 81.52 percent increase over losses of $(6.60) per share from the same period last year. The company reported quarterly sales of $53.30 million which beat the analyst consensus estimate of $52.41 million by 1.70 percent. This is a 35.96 percent decrease over sales of $83.23 million the same period last year.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via